Hsu Frank J.
Insider CIK 1786723 · ONCT Chief Medical Officer · APGN Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 27,000 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer deriv | 2023-08-23 | 2023-08-25 | 224,872 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | D To issuer | 2023-08-23 | 2023-08-25 | 16,354 | — | $0 | 0 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2023-06-15 | 2023-06-23 | 4,323 | $0.49 | $2.1K | 16,354 | SEC↗ |
| APGN Apexigen, Inc. | F Tax w/h | 2022-12-15 | 2022-12-19 | 4,323 | $1.06 | $4.6K | 20,677 | SEC↗ |
| APGN Apexigen, Inc. | A Award deriv | 2022-10-07 | 2022-10-11 | 27,000 | — | $0 | 27,000 | SEC↗ |
| APGN Apexigen, Inc. | A Award | 2022-10-07 | 2022-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 16,280 | — | $0 | 16,280 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-03-18 | 16,280 | — | $0 | 16,280 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-08-26 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-08-26 | 2019-08-28 | 150,000 | — | $0 | 150,000 | SEC↗ |